Welcome to LookChem.com Sign In|Join Free

CAS

  • or

1046815-82-0

3-(1-(5-ethylpyrimidin-2-yl)piperidin-4-yl)propan-1-ol is a complex organic chemical compound characterized by its molecular formula C15H26N2O. It is a derivative of piperidine, featuring a propanol functional group that is attached to the piperidine ring. 3-(1-(5-ethylpyrimidin-2-yl)piperidin-4-yl)propan-1-ol is notable for its pyrimidine ring, which includes an ethyl substituent at the 5-position, and a hydroxyl group on the propanol chain that is connected to the 1-position of the piperidine ring. Its structure suggests potential roles in medicinal chemistry and pharmacology, with the possibility of exhibiting biological activity and serving as a precursor in the synthesis of pharmaceutical compounds. Further research and experimentation are required to explore its specific properties and potential applications.

1046815-82-0 Suppliers

Post Buying Request

Recommended suppliersmore

  • Product
  • FOB Price
  • Min.Order
  • Supply Ability
  • Supplier
  • Contact Supplier

  • 3-(1-(5-ethylpyrimidin-2-yl)piperdin-4-yl)propan-l-ol (Synonyms：4-Pyrimidylpiperidinepropanol) / LIDE PHARMA- Factory supply / Best price

    Cas No: 1046815-82-0

  • USD $ 10.0-10.0 / Gram

  • 1 Gram

  • 10 Metric Ton/Day

  • LIDE PHARMACEUTICALS LIMITED
  • Contact Supplier
  • 1046815-82-0 Structure

  • Basic information

    1. Product Name: 3-(1-(5-ethylpyrimidin-2-yl)piperidin-4-yl)propan-1-ol
    2. Synonyms:
    3. CAS NO:1046815-82-0
    4. Molecular Formula:
    5. Molecular Weight: 249.356
    6. EINECS: N/A
    7. Product Categories: N/A
    8. Mol File: 1046815-82-0.mol

  • Chemical Properties

    1. Melting Point: N/A
    2. Boiling Point: 420.3±37.0 °C(Predicted)
    3. Flash Point: N/A
    4. Appearance: N/A
    5. Density: 1.072±0.06 g/cm3(Predicted)
    6. Refractive Index: N/A
    7. Storage Temp.: N/A
    8. Solubility: N/A
    9. CAS DataBase Reference: 3-(1-(5-ethylpyrimidin-2-yl)piperidin-4-yl)propan-1-ol(CAS DataBase Reference)
    10. NIST Chemistry Reference: 3-(1-(5-ethylpyrimidin-2-yl)piperidin-4-yl)propan-1-ol(1046815-82-0)
    11. EPA Substance Registry System: 3-(1-(5-ethylpyrimidin-2-yl)piperidin-4-yl)propan-1-ol(1046815-82-0)

  • Safety Data

    1. Hazard Codes: N/A
    2. Statements: N/A
    3. Safety Statements: N/A
    4. WGK Germany:
    5. RTECS:
    6. HazardClass: N/A
    7. PackingGroup: N/A
    8. Hazardous Substances Data: 1046815-82-0(Hazardous Substances Data)

1046815-82-0 Usage

Uses

Used in Medicinal Chemistry:
3-(1-(5-ethylpyrimidin-2-yl)piperidin-4-yl)propan-1-ol is used as a chemical intermediate for the synthesis of various pharmaceutical compounds due to its unique structural features and potential biological activity.
Used in Pharmacology Research:
In the field of pharmacology, 3-(1-(5-ethylpyrimidin-2-yl)piperidin-4-yl)propan-1-ol is utilized as a research tool to investigate its potential biological effects and interactions with biological targets, which could lead to the development of new therapeutic agents.
Used in Drug Development:
3-(1-(5-ethylpyrimidin-2-yl)piperidin-4-yl)propan-1-ol is employed as a building block in drug development, where its chemical properties may contribute to the creation of novel medications with specific therapeutic profiles.
Used in Chemical Synthesis Industry:
Within the chemical synthesis industry, 3-(1-(5-ethylpyrimidin-2-yl)piperidin-4-yl)propan-1-ol is used as a key component in the production of complex organic molecules, potentially including those with applications in various sectors such as agriculture, materials science, and specialty chemicals.

Check Digit Verification of cas no

The CAS Registry Mumber 1046815-82-0 includes 10 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 7 digits, 1,0,4,6,8,1 and 5 respectively; the second part has 2 digits, 8 and 2 respectively.
Calculate Digit Verification of CAS Registry Number 1046815-82:
(9*1)+(8*0)+(7*4)+(6*6)+(5*8)+(4*1)+(3*5)+(2*8)+(1*2)=150
150 % 10 = 0
So 1046815-82-0 is a valid CAS Registry Number.

1046815-82-0Downstream Products

1046815-82-0Relevant articles and documents

COMPOUND HAVING GPR119 AGONISTIC ACTIVITY, METHOD FOR PREPARING THE SAME, AND PHARMACEUTICAL COMPOSITION INCLUDING THE SAME AS EFFECTIVE COMPONENT

-

Page/Page column 37, (2016/05/19)

The present invention relates to a novel compound having a GPR1 19 agonistic activity, a method for preparing the same, and a pharmaceutical composition including the same as an effective component. The present invention has an effective hypoglycemic acti

Synthesis and SAR studies of bicyclic amine series GPR119 agonists

Sakairi, Masao,Kogami, Masakazu,Torii, Masafumi,Kataoka, Hiroyo,Fujieda, Hiroki,Makino, Mitsuhiro,Kataoka, Daisuke,Okamoto, Ryuji,Miyazawa, Toshiyuki,Okabe, Morio,Inoue, Megumi,Takahashi, Naoki,Harada, Satoko,Watanabe, Nobuhide

, p. 5123 - 5128 (2012/08/28)

We disclosed a novel series of G-protein coupled receptor 119 (GPR119) agonists based on a bicyclic amine scaffold. Through the optimization of hit compound 1, we discovered that the basic nitrogen atom of bicyclic amine played an important role in GPR119 agonist activity expression and that an indanone in various bicyclic rings was suitable in this series of compounds. The indanone derivative 2 showed the effect of plasma glucose control in oGTT and scGTT in the rodent model.

HETEROCYCLIC GPCR AGONISTS

-

Page/Page column 34, (2010/04/03)

Compounds of formula (I) or pharmaceutically acceptable salts thereof, are GPCR (GPR119) agonists and are useful as for the treatment of diabetes and obesity.

COMPOUNDS AND COMPOSITIONS AS MODULATORS OF GPR119 ACTIVITY

-

, (2009/10/18)

The invention provides compounds of Formula (I): pharmaceutical compositions comprising such compounds and methods of using such compounds to treat or prevent diseases or disorders associated with the activity of GPR119.

COMPOUNDS AND COMPOSITIONS AS MODULATORS OF GPR119 ACTIVITY

-

Page/Page column 52-53, (2008/12/08)

The invention provides compounds, pharmaceutical compositions comprising such compounds and methods of using such compounds to treat or prevent diseases or disorders associated with the activity of GPR119.

Post a RFQ

Enter 15 to 2000 letters.Word count: 0 letters

Attach files(File Format: Jpeg, Jpg, Gif, Png, PDF, PPT, Zip, Rar,Word or Excel Maximum File Size: 3MB)

1

What can I do for you?
Get Best Price

Get Best Price for 1046815-82-0